The Hodges Review gauges public support for the UK’s ‘accidental’ cannabis sector

The main objective of the Hodges Review was to examine the current cannabis sector landscape and outline how best to support the safe and responsible growth – economic and social – of a sizeable and dynamic legal sector that is already established in the UK.  Despite the growth potential and dedication within the industry, the report […]

CBD in food: 12,000 products now pending authorisation as FSA releases final list

The Food Standards Agency has updated the public list of CBD products, adding an additional 6,000 products. This is the complete list of ingestible CBD products currently allowed to remain on the market, which have been linked to a credible novel foods application.    These are the only ingestible CBD products which can be sold […]

FSA issues clarification and new deadline for toxicology data

A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products.  Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]

British Cannabis snags Elixinol license

Australian CBD brand, Elixinol, is set to return to the UK market, following a new licensing and distribution agreement with British Cannabis. In 2021, Elixinol announced plans to cease trading in the UK and European Union in order to focus its attention on the US and Australian markets. The company said that decision was down […]